Industry Soundbites
PharmaVOICE Editor's Take Videos enhance some of our popular topics with additional analysis and insights. Recorded on site at some of the industry's hottest events, Editor's Take Videos help keep you on top of the latest trends and challenges facing the industry.
Click below to browse our library:
Chatting with the Editor
 GSK, Mike Pucci
2009 Annual DIA Meeting
Aureus Research Consultants, Alicia Pouncey
BioClinica, Inc., Mark Weinstein
Criterium, Inc., Lawrence Reiter, Ph.D.
i3 Informatics, Bill Guinn
inVentiv Clinical, Jaye Thompson
Medidata, Graham Bunn
Omnicare Clinical Research, Nancy Meyerson-Hess
United Biosource Corporation, Patrick Lindsay
2008 Annual DIA Meeting
Actelion, Massimo Raineri
Acurian, Scott Connor
Aureus Research Consultants,
Alicia Pouncey
Beardsworth, Dan Diaz
Clinlogix, JeanMarie Markham
Clinsys, David Williams
CRF, Pamela McNamara
Criterium, Kabelo Pududu
CRN, Gail Adinamis
D. Anderson & Co.,
Melynda Geurts
DataTrial, Gill Hallet
DSG, Tony Varano
etrials, Michael Mickens
Icon, Dr. Suzanne Gagnon
Imperial, Robert McGrath
INC Research, Alistair Macdonald
Inclinix, Tobin Geatz
inVentiv Clinical Solutions,
Dr. Scott Treiber
Kendle, Dr. Janet Jones
KForce, Eleanore Doyle
Medidata, Ed Sequine
MedPoint Communications,
Bill Cooney
Microsoft, Michael Naimoli
Monitorforhire, Scott Freedman
Nextrials, James Rogers
Octagon, Jim Walker
Patient Interaction (Pi), Bob Loll
Patni, Steve Jolley
PHT, Sheila Rocchio
PPD, James Streeter
ProTrials, Jodi Andrews
Rigel Pharmaceuticals,
Theresa Kane Musser
SAFE-BioPharma Association,
Mollie Shields Uehling
TechTeam, Joanna Gutkowski
Wyeth, Dr. William Jacobson
|
From the Show Floor — 2009 DIA Meeting
 |
Aureus Research Consultants
|
| Date Recorded: 6/24/09 |
Length: 03:13 |
Size: 11.1MB |
Thought Leader: Alicia Pouncey, M.Ed., Managing Director, Aureus Research Consultants
Alicia discusses using medical simulation for CRA training, how technology-based training benefits younger CRAs, and offers some best practices for maintaining protocol compliance. |
Watch Video  |
|
|
 |
BioClinica
|
| Date Recorded: 6/24/09 |
Length: 02:34 |
Size: 6.9MB |
Thought Leader: Mark Weinstein, President & CEO, BioClinica, Inc.
Mark talks about combining Medical Imaging with EDC and offers advice to sponsors regarding this integration. |
| Watch Video |
|
|
 |
Criterium, Inc.
|
| Date Recorded: 6/24/09 |
Length: 02:38 |
Size: 10.1MB |
Thought Leader: Lawrence Reiter, Ph.D., Director of Global Affairs, Criterium, Inc.
Lawrence discusses how CROs can differentiate themselves, full-service vs. a la carte services, and integrating multiple CROs within a project.
|
| Watch Video |
|
|
 |
i3 Informatics
|
| Date Recorded: 6/24/09 |
Length: 03:31 |
Size: 12.3MB |
Thought Leader: Bill Guinn, VP of Clinical Informatics, i3 Informatics
Bill offers insights on data mining for patients for clinical trials.
|
| Watch Video |
|
|
 |
inVentiv Clinical
|
| Date Recorded: 6/24/09 |
Length: 02:32 |
Size: 10.1MB |
Thought Leader: Jaye Thompson, Ph.D., Senior VP, inVentiv Clinical
Jaye discusses the adaptive outsourcing model, regulatory challenges, and communicating risks to the public.
|
| Watch Video |
|
|
 |
Medidata
|
| Date Recorded: 6/24/09 |
Length: 05:22 |
Size: 18.9MB |
Thought Leader: Graham Bunn, VP, Global CRO Partnerships, Medidata
Graham talks about EDC's impact on clinical monitoring and how numerous new technologies are affecting clinical roles. |
| Watch Video |
|
|
 |
Omnicare Clinical Research
|
| Date Recorded: 6/24/09 |
Length: 03:25 |
Size: 11.6MB |
Thought Leader: Nancy Meyerson-Hess, MSc, Senior VP, Project Management International, Omnicare Clinical Research
Nancy talks about strategic project management and the skill set needed by today's project managers.
|
| Watch Video |
|
|
 |
United BioSource Corporation
|
| Date Recorded: 6/24/09 |
Length: 06:35 |
Size: 23.1MB |
Thought Leader: Patrick Lindsay, EVP, United Biosource Corporation
Patrick discuss risk management and navigating the regulatory environment.
|
| Watch Video |
|
|
From the Show Floor — 2008 DIA Meeting
 |
Actelion
|
| Date Recorded: 6/22/08 |
Length: 01:48 |
Size: 2.8MB |
Thought Leader: Massimo Raineri, Head of Systems Development - Biometry, Actelion
Massimo talks about the complexity of global drug development. |
| Watch Video |
|
|
 |
Acurian
|
| Date Recorded: 6/22/08 |
Length: 01:56 |
Size: 6.6MB |
Thought Leader: Scott Connor, VP, Marketing, Acurian
Scott discusses why patient recruitment remains a major industry challenge.
|
| Watch Video |
|
|
 |
Aureus Research Consultants
|
| Date Recorded: 6/22/08 |
Length: 02:02 |
Size: 6.9MB |
Thought Leader: Alicia Pouncey, Med., Managing Dir., Aureus Research Consultants
Alicia identifies clinical staffing and education as two major challenges. |
| Watch Video |
|
|
 |
Beardsworth
|
| Date Recorded: 6/22/08 |
Length: 01:06 |
Size: 3.7MB |
Thought Leader: Dan Diaz, VP, Business Development, Beardsworth
Dan says the industry needs to overcome the challenge of enrolling quality subjects into complex trials. |
| Watch Video |
|
|
 |
Clinlogix
|
| Date Recorded: 6/22/08 |
Length: 01:54 |
Size: 6.1MB |
Thought Leader: JeanMarie Markham, President/CEO, Clinlogix
JeanMarie discusses why the loss of experienced people due to mergers will impact trials.
|
| Watch Video |
|
|
 |
Clinsys
|
| Date Recorded: 6/22/08 |
Length: 01:22 |
Size: 2.1MB |
Thought Leader: David Williams, CEO, Clinsys
David addresses the need to deliver quality services to industry sponsors.
|
| Watch Video |
|
|
 |
CRF
|
| Date Recorded: 6/22/08 |
Length: 02:35 |
Size: 9.5MB |
Thought Leader: Pamela McNamara, CEO, CRF
Pam outlines five major issues that are impacting the clinical trial space.
|
| Watch Video |
|
|
 |
Criterium
|
| Date Recorded: 6/22/08 |
Length: 01:09 |
Size: 1.8MB |
Thought Leader: Kabelo Pududu, CRA, Criterium
Kabelo says finding investigators for clinical trials is a major challenge.
|
| Watch Video |
|
|
 |
CRN
|
| Date Recorded: 6/22/08 |
Length: 01:40 |
Size: 5.7MB |
Thought Leader: Gail Adinamis, President/CEO, CRN
Gail confirms patient recruitment and retention are still impacting clinical trial efficiency.
|
| Watch Video |
|
|
 |
D. Anderson & Co.
|
| Date Recorded: 6/22/08 |
Length: 01:34 |
Size: 5.3MB |
Thought Leader: Melynda Geurts, COO, D. Anderson & Company
Meylnda talks about the challenges involved with the ongoing delays with trials.
|
| Watch Video |
|
|
 |
DataTrial
|
| Date Recorded: 6/22/08 |
Length: 01:20 |
Size: 4.2MB |
Thought Leader: Gill Hallet, M.Sc., Dir., European Operations, DataTrial
Gill talks about the need for speed in clinical trials.
|
| Watch Video |
|
|
 |
DSG
|
| Date Recorded: 6/22/08 |
Length: 01:57 |
Size: 6.9MB |
Thought Leader: Tony Varano, President/CEO, DSG
Tony discusses the need for re-tooling the clinical process.
|
| Watch Video |
|
|
 |
etrials
|
| Date Recorded: 6/22/08 |
Length: 01:58 |
Size: 6.6MB |
Thought Leader: Michael Mickens, VP, Sales and Client Services, etrials
Michael discusses the need for technology integration.
|
| Watch Video |
|
|
 |
Icon
|
| Date Recorded: 6/22/08 |
Length: 01:49 |
Size: 2.8MB |
Thought Leader: Suzanne Gagnon, M.D., Senior VP, Icon
Dr. Gagnon talks about the public perception regarding drug safety.
|
| Watch Video |
|
|
 |
Imperial
|
| Date Recorded: 6/22/08 |
Length: 01:32 |
Size: 5.1MB |
Thought Leader: Robert McGrath, Sales & Marketing Mgr., Imperial
Bob talks about risk mitigation and why this is a major challenge.
|
| Watch Video |
|
|
 |
INC Research
|
| Date Recorded: 6/22/08 |
Length: 02:54 |
Size: 10.8MB |
Thought Leader: Alistair Macdonald, Sr. VP, Data Services, INC Research
Alistair discusses the changing role of CROs.
|
| Watch Video |
|
|
 |
Inclinix
|
| Date Recorded: 6/22/08 |
Length: 02:25 |
Size: 8.2MB |
Thought Leader: Tobin Geatz, CEO and Chairman, Inclinix
Tobin says the drug development process needs to change.
|
| Watch Video |
|
|
 |
inVentiv Clinical Solutions
|
| Date Recorded: 6/22/08 |
Length: 01:49 |
Size: 6.1MB |
Thought Leader: Dr. Scott Treiber, Sr. VP, Clinical Operations, inVentiv Clinical Solutions
Dr. Treiber says speed, global development, and staffing are three major issues. |
| Watch Video |
|
|
 |
Kendle
|
| Date Recorded: 6/22/08 |
Length: 01:23 |
Size: 4.6MB |
Thought Leader: Dr. Janet Jones, Director, Feasibility & Patient Recruitment, Kendle
Dr. Jones says shrinking patient pools are affecting recruitment. |
| Watch Video |
|
|
 |
KForce
|
| Date Recorded: 6/22/08 |
Length: 01:33 |
Size: 2.4MB |
Thought Leader: Eleanore Doyle, VP, Business Development, KForce
Eleanor says the rising costs of drug development are impacting cycle times.
|
| Watch Video |
|
|
 |
Medidata
|
| Date Recorded: 6/22/08 |
Length: 02:12 |
Size: 7.5MB |
Thought Leader: Ed Sequine, General Mgr., Medidata
Ed believes managing the ever-increasing complexity of the entire pharmaceutical industry is a major challenge. |
| Watch Video |
|
|
 |
MedPoint Communications
|
| Date Recorded: 6/22/08 |
Length: 02:08 |
Size: 7.4MB |
Thought Leader: Bill Cooney, President/CEO, MedPoint Communications
Bill talks about the need to improve research productivity to offset the expense of developing new drugs. |
| Watch Video |
|
|
 |
Microsoft
|
| Date Recorded: 6/22/08 |
Length: 03:01 |
Size: 10.3MB |
Thought Leader: Michael Naimoli, Director, Life Sciences Industry Solutions, Microsoft
Michael says continuing to innovate in a risk-averse environment is a major challenge. |
| Watch Video |
|
|
 |
Monitorforhire
|
| Date Recorded: 6/22/08 |
Length: 01:12 |
Size: 4.2MB |
Thought Leader: Scott Freedman, President, Monitorforhire
Scott discusses the need for quality individuals and for training.
|
| Watch Video |
|
|
 |
Nextrials
|
| Date Recorded: 6/22/08 |
Length: 01:27 |
Size: 4.9MB |
Thought Leader: James Rogers, President/CEO, Nextrials
James talks about how the increasing costs of drug development are impacting companies. |
| Watch Video |
|
|
 |
Octagon
|
| Date Recorded: 6/22/08 |
Length: 01:21 |
Size: 4.5MB |
Thought Leader: Jim Walker, CEO, Octagon
Jim discusses the need for processes as a way to increase efficiencies.
|
| Watch Video |
|
|
 |
Patient Interaction (Pi)
|
| Date Recorded: 6/22/08 |
Length: 01:07 |
Size: 3.7MB |
Thought Leader: Bob Loll, VP, Business Development, Patient Interaction (Pi)
Bob talks about the misperceptions surrounding clinical trials and the need to increase the value of the trial process. |
| Watch Video |
|
|
 |
Patni
|
| Date Recorded: 6/22/08 |
Length: 02:28 |
Size: 8.6MB |
Thought Leader: Steve Jolley, VP, Pharmacovigilance, Patni
Steve identifies increasing pressure from regulators to address safety concerns as a major challenge. |
| Watch Video |
|
|
 |
PHT
|
| Date Recorded: 6/22/08 |
Length: 01:40 |
Size: 5.5MB |
Thought Leader: Sheila Rocchio, VP Marketing, PHT
Sheila says clients are forced to do more with fewer resources.
|
| Watch Video |
|
|
 |
PPD
|
| Date Recorded: 6/22/08 |
Length: 01:32 |
Size: 5.0MB |
Thought Leader: James Streeter, Executive Dir., EDC, PPD
James discusses how regulatory controls, rising costs, and patient recruitment are impacting large and small companies. |
| Watch Video |
|
|
 |
ProTrials
|
| Date Recorded: 6/22/08 |
Length: 01:30 |
Size: 5.0MB |
Thought Leader: Jodi Andrews, President/CEO, ProTrials
Jodi identifies the global factors that are impacting clinical research.
|
| Watch Video |
|
|
 |
Rigel Pharmaceuticals
|
| Date Recorded: 6/22/08 |
Length: 01:21 |
Size: 4.4MB |
Thought Leader: Theresa Kane Musser, Exec. Dir., Development Operations, Rigel Pharmaceuticals
Theresa talks about the need for excellent science. |
| Watch Video |
|
|
 |
SAFE-BioPharma Association
|
| Date Recorded: 6/22/08 |
Length: 01:44 |
Size: 5.7MB |
Thought Leader: Mollie Shields Uehling, President/CEO, SAFE-BioPharma Association
Mollie says the biggest challenge today is getting innovative products to patients faster. |
| Watch Video |
|
|
 |
TechTeam
|
| Date Recorded: 6/22/08 |
Length: 01:11 |
Size: 3.8MB |
Thought Leader: Joanna Gutkowski, Acct. Mgr., TechTeam
Joanna says in light of acquisitions there is a need for cost-effective solutions.
|
| Watch Video |
|
|
 |
Wyeth
|
| Date Recorded: 6/22/08 |
Length: 01:38 |
Size: 5.4MB |
Thought Leader: Dr. William Jacobson, Dir. Project Mgmt., Wyeth
Dr. Jacobson identifies the enormous changes in the regulatory environment as having a major impact. |
| Watch Video |
|
|
|
